caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1245506237

Matthew FlynnM.D.

Pulmonary DiseaseVancouver, WAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (2)

CCN 380091
Hospital
CCN 380103
Hospital
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
962
Beneficiaries
—
Total drug cost
$415K
Distinct drugs
19
Brand share
63.6%
Top prescribed drugs
Fluticasone Propion/Salmeterol159 claims
Azithromycin128 claims
Prednisone128 claims
Albuterol Sulfate101 claims
Ciclesonide84 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
13
Unique beneficiaries
—
Total services
21
Distinct HCPCS
1
Medicare payment
$3K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 228 Pulmonary Disease providers in WA — bottom quintile (cohort median 454).